Regulators Reassure On AZ Vaccine Safety After Rare Side Effect Deemed Plausible
Vaccine Faces Global Confidence Test
Executive Summary
The EMA and MHRA issue parallel safety updates on the vaccine, with the UK offering an alternative of the Pfizer/BioNTech or Moderna vaccines to the under 30s.
You may also be interested in...
Has UK Got Vaccine Strategy Right Again With Choice For Under 30s?
The UK has announced a ‘course correction’ on its vaccination program, and looks to have maintained public confidence so far – unfortunately the same cannot be said for EU countries
Regulators Reassure On AZ Vaccine Safety After Rare Side Effect Deemed Plausible
The EMA and MHRA issue parallel safety updates on the vaccine, with the UK offering an alternative of the Pfizer/BioNTech or Moderna vaccines to the under 30s.
EMA Expected To Confirm AZ Vaccine Link To Rare Blood Clot
Growing evidence of an association between the vaccine and rare, sometimes fatal blood clots puts Europe’s vaccine program leaders in a difficult position.